Denali Therapeutics Stock Price. Everything You Need To Know About The Denali Therapeutics Stock!
Denali Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates for neurodegenerative diseases. The company is headquartered in South San Francisco, California and currently employs 427 full-time employees. The company went IPO on 2017-12-08. The firm is focused on developing a portfolio of product candidates engineered to cross the blood-brain barrier (BBB) for neurodegenerative diseases and lysosomal storage disease. The Company’s clinical-stage programs include Antibody Transport Vehicle (ATV): triggering receptors expressed on myeloid cells 2 (TREM2), Protein Transport Vehicle (PTV): progranulin (PGRN), eukaryotic initiation factor 2 B (eIF2B), receptor-interacting serine/threonine protein kinase 1 (RIPK1), Enzyme Transport Vehicle (ETV): iduronate 2-sulfatase (IDS) and leucine-rich repeat kinase 2 (LRRK2), which are in various Phases ranging from Phase I through Phase III. The Company’s product candidates include DNL310, TAK-594/DNL593, TAK-920/DNL919, BIIB122/DNL151, DNL343, SAR443820/DNL788 and SAR443122/DNL758. The firm engineers its product candidates to cross the BBB, and act directly in the brain.
Denali Therapeutics Stock Price. Everything You Need To Know About The Denali Therapeutics Stock! performance
- Employees 427
- Company HQ South San Francisco
- Website https://www.denalitherapeutics.com
- DNLI Asset Type Common Stock
- DNLI Market Capitalization 2.2B
- Earnings Per Share -1.06
- Dividends Per Share None
- Dividend Date None
- Quarterly Earnings Growth 0
Are you a retail investor from Malaysia, Thailand, Indonesia or Vietnam looking to invest in innovative and promising stocks? Look no further than Denali Therapeutics. As a leading content marketing expert at Zorion, I am here to provide you with insights on how to invest in this exciting stock. Denali Therapeutics is a biopharmaceutical company focused on developing breakthrough therapies for neurodegenerative diseases like Parkinson’s and Alzheimer’s. With its cutting-edge science and a strong pipeline of potential treatments, Denali presents a compelling investment opportunity. To invest in Denali Therapeutics from Malaysia, Thailand, Indonesia, or Vietnam, follow these simple steps. Firstly, open an account with Zorion, our trusted investment platform. Next, ensure you have sufficient funds in your account. Then, search for Denali Therapeutics stock using the ticker symbol DNLI” on the platform. Finally, click on the “Buy” button to initiate your investment. If you’re new to investing or want to enhance your knowledge, Zorion offers educational resources and materials to help you make informed decisions. Stay updated with market trends and research reports provided by our expert team. Investing in Denali Therapeutics can be a rewarding endeavor if you approach it wisely. With Zorion’s investment insights and recommendations, you can confidently navigate the market and potentially earn attractive returns on your investment. Don’t miss out on this opportunity to support groundbreaking advancements in healthcare while growing your wealth. Start your investment journey with Zorion and invest in Denali Therapeutics today.”
